Bioceres Crop Solutions Corp (NASDAQ: BIOX) has a price-to-earnings ratio of 441.30x that is above its average ratio. Additionally, the 36-month beta value for BIOX is 0.54. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for BIOX is 32.43M and currently, short sellers hold a 2.06% ratio of that float. The average trading volume of BIOX on December 20, 2024 was 192.86K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
BIOX) stock’s latest price update
The stock of Bioceres Crop Solutions Corp (NASDAQ: BIOX) has decreased by -6.88 when compared to last closing price of 6.54.Despite this, the company has seen a loss of -7.87% in its stock price over the last five trading days. seekingalpha.com reported 2024-11-12 that Bioceres’ 1Q25 results were challenging due to adverse weather in Argentina, affecting crop nutrition, protection, and seeds, but potential recovery is expected in 2Q25. BIOX has depreciated significantly, now trading at $6.7 per share, with a market cap of $400 million, making it a more interesting Hold. Despite some improvements, HB4 commercialization remains underwhelming, and financial risks persist, warranting caution before investing in potential developments.
BIOX’s Market Performance
BIOX’s stock has fallen by -7.87% in the past week, with a monthly drop of -4.25% and a quarterly drop of -26.09%. The volatility ratio for the week is 7.21% while the volatility levels for the last 30 days are 5.98% for Bioceres Crop Solutions Corp The simple moving average for the past 20 days is -8.92% for BIOX’s stock, with a -38.48% simple moving average for the past 200 days.
Analysts’ Opinion of BIOX
Many brokerage firms have already submitted their reports for BIOX stocks, with Canaccord Genuity repeating the rating for BIOX by listing it as a “Buy.” The predicted price for BIOX in the upcoming period, according to Canaccord Genuity is $17 based on the research report published on July 19, 2024 of the current year 2024.
ROTH MKM, on the other hand, stated in their research note that they expect to see BIOX reach a price target of $15. The rating they have provided for BIOX stocks is “Buy” according to the report published on July 02nd, 2024.
Oppenheimer gave a rating of “Outperform” to BIOX, setting the target price at $15 in the report published on April 06th of the previous year.
BIOX Trading at -10.28% from the 50-Day Moving Average
After a stumble in the market that brought BIOX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -56.65% of loss for the given period.
Volatility was left at 5.98%, however, over the last 30 days, the volatility rate increased by 7.21%, as shares sank -5.73% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.26% lower at present.
During the last 5 trading sessions, BIOX fell by -7.87%, which changed the moving average for the period of 200-days by -53.26% in comparison to the 20-day moving average, which settled at $6.69. In addition, Bioceres Crop Solutions Corp saw -55.64% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for BIOX
Current profitability levels for the company are sitting at:
- 0.09 for the present operating margin
- 0.4 for the gross margin
The net margin for Bioceres Crop Solutions Corp stands at 0.01. The total capital return value is set at 0.08. Equity return is now at value 0.50, with 0.18 for asset returns.
Based on Bioceres Crop Solutions Corp (BIOX), the company’s capital structure generated 0.45 points at debt to capital in total, while cash flow to debt ratio is standing at 0.08. The debt to equity ratio resting at 0.81. The interest coverage ratio of the stock is 1.66.
Currently, EBITDA for the company is 55.46 million with net debt to EBITDA at 5.83. When we switch over and look at the enterprise to sales, we see a ratio of 1.4. The receivables turnover for the company is 2.01for trailing twelve months and the total asset turnover is 0.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.27.
Conclusion
In conclusion, Bioceres Crop Solutions Corp (BIOX) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
